Adenosine deaminase acting on RNA 1 p150 and p110 are involved in the proliferation，migration，and invasion of liver cancer cells

Gong Xue; Liu Jing; Jian Wenwen; Cui Yihong; Tu Zeng

doi:10.13406/j.cnki.cyxb.003544

您当前的位置：

首页 >

文章列表页 >

Adenosine deaminase acting on RNA 1 p150 and p110 are involved in the proliferation，migration，and invasion of liver cancer cells

Basic research | 更新时间：2025-10-21

- Adenosine deaminase acting on RNA 1 p150 and p110 are involved in the proliferation，migration，and invasion of liver cancer cells
- Journal of Chongqing Medical University Vol. 49, Issue 7, Pages: 820-829(2024)
- 作者机构：
  
  重庆医科大学基础医学院病原生物学教研室，重庆 400016
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.003544
  CLC： R735.7
- Received：25 January 2024，
  
  Revised：2024-04-25，
  
  Accepted：28 April 2024，
  
  Published：28 July 2024
- 稿件说明：
移动端阅览
巩雪,柳静,蹇文文,等.ADAR1 p150和p110参与肝癌细胞增殖、迁移和侵袭[J].重庆医科大学学报,2024,49(7):820-829.

Gong Xue,Liu Jing,Jian Wenwen,et al.Adenosine deaminase acting on RNA 1 p150 and p110 are involved in the proliferation，migration，and invasion of liver cancer cells[J].Journal of Chongqing Medical University,2024,49(7):820-829.
巩雪,柳静,蹇文文,等.ADAR1 p150和p110参与肝癌细胞增殖、迁移和侵袭[J].重庆医科大学学报,2024,49(7):820-829. DOI： 10.13406/j.cnki.cyxb.003544.

Gong Xue,Liu Jing,Jian Wenwen,et al.Adenosine deaminase acting on RNA 1 p150 and p110 are involved in the proliferation，migration，and invasion of liver cancer cells[J].Journal of Chongqing Medical University,2024,49(7):820-829. DOI： 10.13406/j.cnki.cyxb.003544.

摘要

目的

研究腺苷脱氨酶1（adenosine deaminase acting on RNA 1，ADAR1）对肝细胞癌（liver hepatocellular carcinoma，LIHC）增殖、迁移与侵袭的影响。

方法

利用基因表达谱交互式分析网站GEPIA检测ADAR1在LIHC中的表达水平和预后价值；提取人体肝癌标本的蛋白，通过Western blot实验检测ADAR1的表达情况。将ADAR1 p150和p110过表达质粒和靶向ADAR1 p150和p110的小干扰RNA分别转染进HepG2和Huh7细胞，利用Western blot和qPCR检测转染后细胞的ADAR1表达情况。通过CCK-8实验检测ADAR1对肝癌细胞增殖能力的影响。通过细胞划痕实验和Transwell实验检测ADAR1对肝癌细胞迁移和侵袭的影响。最后，在DAVID在线数据库中分析与ADAR1相关的信号通路，利用Western blot实验检测信号通路中相关蛋白的表达。

结果

肝癌组织中ADAR1蛋白质水平明显高于癌旁组织，这与生物信息学的预测一致，且高表达的ADAR1与肝癌的不良预后相关；通过CCK-8实验，本研究发现过表达ADAR1可以促进肝癌细胞的增殖能力（

0.05），敲低ADAR1使肝癌细胞增殖能力下降（

0.05）。通过划痕和Transwell实验，本研究发现ADAR1的过表达促进了肝癌细胞的迁移和侵袭（

0.05），敲低ADAR1后，肝癌细胞迁移和侵袭能力受到抑制（

0.05）。DAVID在线分析结果显示，AD

AR1主要富集在Wnt信号通路中。Western blot结果提示，过表达ADAR1抑制GSK3β表达和β-catenin的磷酸化水平，敲低ADAR1后GSK3β表达和β-catenin的磷酸化水平升高。

结论

本研究结果表明，ADAR1在肝癌中处于高表达水平，可激活Wnt/β-catenin信号通路，从而促进肝癌的增殖、迁移和侵袭。

Abstract

Objective

To investigate the effect of adenosine deaminase acting on RNA 1（ADAR1） on the proliferation，migration，and invasion of liver hepatocellular carcinoma（LIHC） cells.

Methods

The gene expression profiling interactive analysis website GEPIA was used to obtain the expression level and prognostic value of ADAR1 in LIHC； proteins were extracted from human hepatocellular carcinoma specimens，and Western blot was used to measure the expression level of ADAR1. HepG2 and Huh7 cells were transfected with ADAR1 p150 and p110 overexpression plasmids or small interfering RNAs targeting both ADAR1 p150 and p110，and Western blot and qPCR were used to measure the expression of ADAR1 in cells after transfection. CCK-8 assay was used to observe the effect of ADAR1 on the proliferative ability of hepatocellular carcinoma cells，and scratch assay and Transwell assay were used to observe the effect of ADAR1 on the migration and invasion of LIHC cells. Finally，the DAVID online database was used to analyze the signaling pathways related to ADAR1，and Western blot was used to measure the expression of proteins associated with the signaling pathways.

Results

The protein expression level of ADAR1 in hepatocellular carcinoma tissue was significantly higher than that in paracancerous tissue，which was consistent with the prediction based on bioinformatics，and the high expression of ADAR1 was associated with the poor prognosis of hepatocellular carcinoma. CCK-8 assay showed that overexpression of ADAR1 promoted the proliferation ability of hepatocellular carcinoma cells（

0.05），and knockdown of ADAR1 reduced the proliferation ability of hepatocellular carcinoma cel

ls（

0.05）. Scratch assay and Transwell assay showed that overexpression of ADAR1 significantly promoted the migration and invasion of hepatocellular carcinoma cells（

0.05），and knockdown of ADAR1 inhibited the migration and invasion abilities of hepatocellular carcinoma cells（

0.05）. The results of DAVID online analysis showed that ADAR1 was mainly enriched in the Wnt signaling pathway. Western blot showed that overexpression of ADAR1 inhibited the expression of GSK3β and the phosphorylation level of β-catenin，and knockdown of ADAR1 increased the expression of GSK3β and the phosphorylation level of β-catenin.

Conclusion

The results of this study show that there is a high expression level of ADAR1 in LIHC，which can activate the Wnt/β-catenin signaling pathway and thus promote the proliferation，migration，and invasion of hepatocellular carcinoma.

关键词

Keywords

references

Anwanwan D ， Singh SK ， Singh S ， et al . Challenges in liver cancer and possible treatment approaches [J ] . Biochim Biophys Acta Rev Cancer ， 2020 ， 1873 （ 1 ）： 188314 ．

Sperandio RC ， Pestana RC ， Miyamura BV ， et al . Hepatocellular carcinoma immunotherapy [J ] . Annu Rev Med ， 2022 ， 73 ： 267 - 278 ．

Llovet JM ， De Baere T ， Kulik L ， et al . Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma [J ] . Nat Rev Gastroenterol Hepatol ， 2021 ， 18 （ 5 ）： 293 - 313 ．

Jiang C ， Sun XD ， Qiu W ， et al . Conversion therapy in liver transplantation for hepatocellular carcinoma：what’s new in the era of molecular and immune therapy? [J ] . Hepatobiliary Pancreat Dis Int ， 2023 ， 22 （ 1 ）： 7 - 13 ．

Cannella R ， Lewis S ， da Fonseca L ， et al . Immunotherapy-based treatments of hepatocellular carcinoma：AJR expert panel narrative review [J ] . AJR Am J Roentgenol ， 2022 ， 219 （ 4 ）： 533 - 546 ．

Li H ， Wu ZY ， Chen JL ， et al . External radiotherapy combined with sorafenib has better efficacy in unresectable hepatocellular carcinoma：a systematic review and meta-analysis [J ] . Clin Exp Med ， 2023 ， 23 （ 5 ）： 1537 - 1549 ．

Guo LL ， Hu CT ， Yao MW ， et al . Mechanism of sorafenib resistance associated with ferroptosis in HCC [J ] . Front Pharmacol ， 2023 ， 14 ： 1207496 ．

Shen HQ ， An O ， Ren X ， et al . ADARs act as potent regulators of circular transcriptome in cancer [J ] . Nat Commun ， 2022 ， 13 （ 1 ）： 1508 ．

Sun T ， Yu YP ， Wu XF ， et al . Decoupling expression and editing preferences of ADAR1 p150 and p110 isoforms [J ] . Proc Natl Acad Sci U S A ， 2021 ， 118 （ 12 ）： e2021757118 ．

Quin J ， Sedmík J ， Vukić D ， et al . ADAR RNA modifications，the epitranscriptome and innate immunity [J ] . Trends Biochem Sci ， 2021 ， 46 （ 9 ）： 758 - 771 ．

Fritzell K ， Xu LD ， Lagergren J ， et al . ADARs and editing：the role of A-to-I RNA modification in cancer progression [J ] . Semin Cell Dev Biol ， 2018 ， 79 ： 123 - 130 ．

Shigeyasu K ， Okugawa Y ， Toden S ， et al . AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer [J ] . JCI Insight ， 2018 ， 3 （ 12 ）： e99976 ．

Dong XQ ， Chen G ， Cai ZX ， et al . CDK13 RNA over-editing mediated by ADAR1 associates with poor prognosis of hepatocellular carcinoma patients [J ] . Cell Physiol Biochem ， 2018 ， 47 （ 6 ）： 2602 - 2612 ．

Luo J ， Gong LQ ， Yang YM ， et al . Enhanced mitophagy driven by ADAR1-GLI1 editing supports the self-renewal of cancer stem cells in HCC [J ] . Hepatology ， 2024 ， 79 （ 1 ）： 61 - 78 ．

Chen LL ， Li Y ， Lin CH ， et al . Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma [J ] . Nat Med ， 2013 ， 19 （ 2 ）： 209 - 216 ．

Baker AR ， Miliotis C ， Ramírez-Moya J ， et al . Transcriptome profiling of ADAR1 targets in triple-negative breast cancer cells reveals mechanisms for regulating growth and invasion [J ] . Mol Cancer Res ， 2022 ， 20 （ 6 ）： 960 - 971 ．

Chan TH ， Lin CH ， Qi LH ， et al . A disrupted RNA editing balance mediated by ADARs（Adenosine DeAminases that act on RNA） in human hepatocellular carcinoma [J ] . Gut ， 2014 ， 63 （ 5 ）： 832 - 843 ．

Yu JJ ， Zhang CJ ， Yu QS ， et al . ADAR1 p110 enhances adhesion of tumor cells to extracellular matrix in hepatocellular carcinoma via up-regulating ITGA2 expression [J ] . Med Sci Monit ， 2019 ， 25 ： 1469 - 1479 ．

王　珉，徐子岩，于　超，等 . 肝脏类器官在肝癌研究中的进展及其应用 [J ] . 中华肝脏病杂志， 2023 ， 31 （ 12 ）： 1332 - 1335 .

Wang M ， Xu ZY ， Yu C ， et al . Progress and application of liver organoids in liver cancer research [J ] . Chin J Hepatol ， 2023 ， 31 （ 12 ）： 1332 - 1335

Murai H ， Kodama T ， Maesaka K ， et al . Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma [J ] . Hepatology ， 2023 ， 77 （ 1 ）： 77 - 91 ．

Hu SB ， Heraud-Farlow J ， Sun T ， et al . ADAR1p150 prevents MDA5 and PKR activation via distinct mechanisms to avert fatal autoinflammation [J ] . Mol Cell ， 2023 ， 83 （ 21 ）： 3869 - 3884.e7 .

Zhang B ， Li Y ， Zhang JY ， et al . ADAR1 links R-loop homeostasis to ATR activation in replication stress response [J ] . Nucleic Acids Res ， 2023 ， 51 （ 21 ）： 11668 - 11687 ．

Yang WD ， Chen KH ， Yu Q ， et al . ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma [J ] . Cancer Med ， 2023 ， 12 （ 13 ）： 14820 - 14832 ．

Cui HW ， Yi Q ， Tian M ， et al . ADAR1 prevents R-loop accumulation-driven ATR pathway activation in ovarian cancer [J ] . J Cancer ， 2022 ， 13 （ 8 ）： 2397 - 2412 ．

Yang Q ， Xu P ， Liu QT ， et al . Depleting DDX1 sensitizes non-small cell lung cancer cells to chemotherapy by attenuating cancer stem cell traits [J ] . Life Sci ， 2023 ， 323 ： 121592 ．

Gajos-Michniewicz A ， Czyz M . WNT/β-catenin signaling in hepatocellular carcinoma：the aberrant activation，pathogenic roles，and therapeutic opportunities [J ] . Genes Dis ， 2024 ， 11 （ 2 ）： 727 - 746 ．

Chen X ， Zhang Y ， Zhang PP ， et al . IGFBP2 drives epithelial-mesenchymal transition in hepatocellular carcinoma via activating the Wnt/β-catenin pathway [J ] . Infect Agent Cancer ， 2023 ， 18 （ 1 ）： 73 ．

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Armadillo repeat containing X-linked 3 regulates the proliferation，migration，and invasion of breast cancer cells

TMEM9 promotes the proliferation and invasion of prostate cancer by affecting autophagy

Effect of hnRNPA2B1-mediated m⁶A modification of MIR100HG in promoting the proliferation and invasion of gastric cancer MKN-28 cells

Effect of METTL3-mediated m⁶A modification of lncRNA SNHG5 on the proliferation and invasion of osteosarcoma MG-63 cells

Related Author

Ma Haixiang

Jiang Zhongyong

Wang Jiandong

Huang Xiyang

Zhang Hong

Huang Xiyang

Jiang Zhongyong

Zhang Hong

Related Institution

School of Laboratory Medicine，Chengdu Medical College

Department of Medical Laboratory，Chengdu Seventh People’s Hospital

School of Bioscience and Technology，Chengdu Medical College

Department of Medical Laboratory & Blood Transfusion，Chengdu Seventh People’s Hospital

Department of Urology，The First Affiliated Hospital of Chongqing Medical University

⁰